Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Additional data confirm clopidogrel-PPI interaction
American Pharmacists Association, 05/29/09
Results from the Clopidogrel Medco Outcomes study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2009 Scientific Sessions showed that 1-year risk of cardiovascular events is increased more than 50% in patients taking a proton-pump inhibitor in combination with clopidogrel post–stent placement compared with patients not on PPI therapy poststenting; the risk appears to be a class effect.
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
In vitro Growth Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
Infection and Immunity, 12/02/09
A Multicenter, Double-Blind, Randomized, Parallel Group Study Comparing Polyvinyl Chloride and Polyvinyl Chloride-Free Catheter Materials
The Journal of Urology, 11/24/09
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09
Sponsor
Article Search
Sponsor


See Latest Articles


